Location: Home
  • search
  • go
  • Relate News
  • 6/28/2023BCHT to Acquire Chinese mRNA Startup Transcend in Phases
  • 6/26/2023Innovent and RemeGen Enter into Clinical Trial Collaboration Investiga...
  • 6/26/2023CDE Solicits Comments on the Technical Guidelines for Non-clinical Res...
  • 6/26/2023Snapshot of Import Drugs Approved by NMPA in 2022 (1)
  • 6/26/2023PODCAST: European Businesses Glum on China, and AstraZeneca Weighs Spi...
  • 6/26/2023China Saw Cross-border Pharma Deals Surge by 68% in May (PharmaDJ)
  • 6/25/2023Recent Executive Moves
  • 6/23/2023Considerations for Registering Pharmaceutical Trademarks in China and ...
  • 6/21/2023CDE Issues on the Technical Guidelines for Clinical Trials of Human-De...
  • 6/21/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
  • 6/20/2023China's Healthcare Integration Reform Advances with over 45% of County...
  • 6/20/2023NMPA to Officially Join PIC/S in 2023 Following Pre-Accession Process
  • 6/20/2023NMPA Restores Import, Sales and Use of Dr. Reddy's Quetiapine Fumarate
  • 6/20/2023AstraZeneca's China Head Dismisses Reports of Potential Spinoff as 'Ru...
  • 6/20/2023China Approves Medivir's Patent Application for Fostrox
  • 6/20/2023Gan & Lee Divests from Russian JV Endogenix
  • 6/20/2023PolyU and TMU Tie Up to Build Joint Ophthalmology Research Platform
  • 6/20/2023Chinese Drugmakers Showcased Clinical Progress in ADC, CAR-T and PD-1 ...
  • 6/18/2023AstraZeneca Considers Spinning Off of Its China Business: FT
  • 6/16/2023China Launches Three-year Campaign to Fight Alzheimer's Disease
  • 6/16/2023U.S. FDA and PhRMA Delegations Visited China, Met by Chinese Officials
  • 6/15/2023Grifols to Sell a Sizable Stake in Shanghai RAAS
  • 6/15/2023NHSA Reports Significant BMI Fund Recovery thru National and Local Hos...
  • 6/15/2023German Businesses Faced Reality Check in China
  • 6/15/2023Swiss Companies Find Renewed Confidence in China's Post-COVID Era
  • 6/15/2023Top Ten Listed Chinese Pharma Companies by R&D Spending in 2021/2022
  • 6/15/2023How Health Technology Reassessment Can Support Disinvestment in China'...
  • 6/15/2023Use of Real-World Data to Improve Drug Coverage Decisions in China (BM...
  • 6/15/2023Health Technology Assessment to Inform Decision Making in China: Progr...
  • 6/14/2023Simcere Pharma Announces Sponsored Research Agreement with Boston-base...
  • Page:23/333 Total number of articles:9989: [First][<<] [21] [22] [23] [24] [25] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group